# FDA Inspection 1097659 - Bloodworks - July 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/08b8b8db-4212-4a65-b7c9-e6c460791fbd
Source feed: FDA_Inspections

> FDA Inspection 1097659 for Bloodworks on July 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097659
- Company Name: Bloodworks
- Inspection Date: 2019-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312306 - 2026-04-08](https://www.keypedia.com/records/fda_inspections/bloodworks/60037618-9b30-412e-98f1-bb3fc7d93558)
- [FDA Inspection 1190669 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/bloodworks/b2afbcce-8b61-4fdd-9201-4e0e1842ec37)
- [FDA Inspection 1190669 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/bloodworks/9017cfff-2068-4afd-9e90-7cf6ff048341)
- [FDA Inspection 983200 - 2016-08-26](https://www.keypedia.com/records/fda_inspections/bloodworks/35d86c89-3ec3-4120-b6b1-94bead0eac1d)
- [FDA Inspection 894094 - 2014-09-05](https://www.keypedia.com/records/fda_inspections/bloodworks/f36d267a-4423-42a6-a7be-28054a9a3c64)

Company: https://www.keypedia.com/companies/bloodworks/3b106ca6-9872-469d-8a0c-33fc636dc74b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d